Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial

Includes bibliographical references (leaves 83-88).

Saved in:
Bibliographic Details
Main Author: Allen, Elizabeth
Other Authors: Boulle, Andrew
Format: Thesis
Language:English
Published: Department of Public Health and Family Medicine 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613174898884608
access_status_str Open Access
author Allen, Elizabeth
author2 Boulle, Andrew
author_browse Allen, Elizabeth
Boulle, Andrew
author_facet Boulle, Andrew
Allen, Elizabeth
author_sort Allen, Elizabeth
collection Thesis
description Includes bibliographical references (leaves 83-88).
format Thesis
id oai:open.uct.ac.za:11427/9321
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:31:56.645Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Department of Public Health and Family Medicine
publisherStr Department of Public Health and Family Medicine
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/9321 Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial Allen, Elizabeth Boulle, Andrew Little, Francesca Public Health Includes bibliographical references (leaves 83-88). [Background and rationale] Malaria accounts for a large public health burden in Mozambique and a treatment policy with effective anti-malarials is a key component of their malaria control programme. Artemisinin-based combination therapies (ACTs) are now generally considered as the best treatment for uncomplicated falciparum malaria; the use of artesunate (AS) in combination with sulfadoxine-pyrimethamine (SP) is recommended by the World Health Organisation (WHO). Mozambique policy-makers recommended that an ACT be implemented and studied in 2003. Therefore this RCT was conducted to compare SP monotherapy with AS, plus SP in order to provide further evidence of available treatment options in the region. [Trial design and methods] A prospective multi-centre, open-label, parallel-group randomised clinical trial (RCT) was conducted at 4 public health facilities in Maputo Province, Mozambique during the malaria seasons of 2003 - 2004 and 2004 - 2005. Eligible patients were aged over 1 year with body weight over 10kg and uncomplicated Plasmodium falciparum malaria (parasitaemia less than 500 000 asexual parasites/ml blood with axillary temperature less than or equal to 37.5oC or a history of fever). Patients were excluded if they took other anti- malarials or folate within 7 days, had moderately severe/severe malaria, history of G6PD deficiency or allergy to study drugs, or serious underlying disease. Patients were randomly assigned to sulfadoxine-pyrimethamine (SP): a single oral 25/1.25mg per kg dose on Day 0, with a maximum of 3 tablets), or artesunate (AS) plus SP: SP as above, plus single oral doses of 4mg/kg AS on Days 0, 1 and 2 with a maximum daily dose of 4 tablets). The study aimed to compare the efficacy of SP monotherapy to SP in combination with AS as first line treatment of uncomplicated falciparum malaria. The primary objective was the comparison of the time to treatment failure (the relative hazard of treatment failure) between groups using standard WHO response to treatment definitions for low to moderate malaria transmission areas, modified to a 42 day follow up. Randomisation was computer-generated with sequential allocation concealed in opaque sealed envelopes. Treatments were open-label, however laboratory staff responsible for parasite density measurements (in order to determine the primary efficacy end point) were blinded to treatment allocation. 2014-11-07T10:10:21Z 2014-11-07T10:10:21Z 2008 Master Thesis Masters MPH http://hdl.handle.net/11427/9321 eng application/pdf Department of Public Health and Family Medicine Faculty of Health Sciences University of Cape Town
spellingShingle Public Health
Allen, Elizabeth
Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial
thesis_degree_str Master's
title Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial
title_full Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial
title_fullStr Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial
title_full_unstemmed Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial
title_short Efficacy of sulfadoxine-pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in Mozambique : a randomised controlled trial
title_sort efficacy of sulfadoxine pyrimethamine with and without artesunate for the treatment of uncomplicated malaria in mozambique a randomised controlled trial
topic Public Health
url http://hdl.handle.net/11427/9321
work_keys_str_mv AT allenelizabeth efficacyofsulfadoxinepyrimethaminewithandwithoutartesunateforthetreatmentofuncomplicatedmalariainmozambiquearandomisedcontrolledtrial